P/B
1,1
Beyond Air
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
$2.2M
Market Cap • 10/9/2026
2015
(11 years)
Founded
2016
(10 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
0,3
P/EBITDA
0,1
P/OCF
—
P/FCF
—
P/E
—
BVPS
2,1
EPS
—
Market Cap
Market Cap
2,2M
EV
16,8M
EV/Revenue
2,2
EV/EBITDA
0,5
EV/EBIT
0,6
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-434,1%
Total Yield
-434,1%
Payout
0%
Retained Earnings
-327,5M
Profitability
Gross Margin
195,8%
EBITDA Margin
415,4%
EBIT Margin
373,2%
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
-54,8%
Capex/Revenue
13,5%
Capex/D&A
31,9%
Capex/OCF
-5,6%
SBC/OCF
—
% PPE
27,3%
% Goodwill
0%
ROE
—
ROIC
167,3%
Growth
CAGR Net Income 5Y
8,5%
CAGR EPS 5Y
-32%
CAGR OCF 5Y
0,5%
Leverage
N.D./EBITDA
0,4
Debt/Equity
0%
Current Ratio
3,3
Quick Ratio
1,6
Interest Coverage
643,4%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!